| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 1.76e-62 | 46 | 34 | 25 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 2.07e-44 | 188 | 34 | 25 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 4.47e-27 | 891 | 34 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.43e-09 | 12 | 34 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 1.73e-05 | 192 | 34 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 8.49e-05 | 268 | 34 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 8.88e-05 | 51 | 34 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.38e-04 | 156 | 34 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.03e-04 | 323 | 34 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.40e-04 | 180 | 34 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.77e-04 | 187 | 34 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 3.65e-04 | 201 | 34 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 7.51e-04 | 105 | 34 | 3 | GO:0004867 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 9.18e-04 | 257 | 34 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | integrin binding | 3.24e-03 | 175 | 34 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 6.14e-03 | 435 | 34 | 4 | GO:0004857 | |
| GeneOntologyMolecularFunction | collagen binding | 8.38e-03 | 81 | 34 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.30e-02 | 102 | 34 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | amide binding | 1.41e-02 | 299 | 34 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 1.79e-02 | 596 | 34 | 4 | GO:0140678 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL19A1 COL28A1 COL27A1 | 5.27e-29 | 377 | 33 | 21 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL19A1 COL28A1 COL27A1 | 5.58e-29 | 378 | 33 | 21 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL19A1 COL28A1 COL27A1 | 5.90e-29 | 379 | 33 | 21 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 6.00e-12 | 12 | 33 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.75e-11 | 76 | 33 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 6.44e-11 | 18 | 33 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | notochord development | 7.38e-06 | 24 | 33 | 3 | GO:0030903 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.53e-05 | 343 | 33 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 2.91e-05 | 228 | 33 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | cartilage development | 3.95e-05 | 243 | 33 | 5 | GO:0051216 | |
| GeneOntologyBiologicalProcess | skeletal system development | 4.40e-05 | 615 | 33 | 7 | GO:0001501 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 1.11e-04 | 10 | 33 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 1.23e-04 | 161 | 33 | 4 | GO:0071230 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 1.77e-04 | 177 | 33 | 4 | GO:0071229 | |
| GeneOntologyBiologicalProcess | complement activation | 1.90e-04 | 70 | 33 | 3 | GO:0006956 | |
| GeneOntologyBiologicalProcess | endothelial cell morphogenesis | 2.57e-04 | 15 | 33 | 2 | GO:0001886 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 2.72e-04 | 79 | 33 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | response to amino acid | 2.92e-04 | 202 | 33 | 4 | GO:0043200 | |
| GeneOntologyBiologicalProcess | synapse pruning | 4.17e-04 | 19 | 33 | 2 | GO:0098883 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 5.44e-04 | 238 | 33 | 4 | GO:0050954 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 6.70e-04 | 957 | 33 | 7 | GO:0097435 | |
| GeneOntologyBiologicalProcess | bone development | 8.02e-04 | 264 | 33 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 9.58e-04 | 277 | 33 | 4 | GO:0048705 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.01e-03 | 124 | 33 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 1.06e-03 | 747 | 33 | 6 | GO:0007169 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 1.24e-03 | 133 | 33 | 3 | GO:0002062 | |
| GeneOntologyBiologicalProcess | cell junction disassembly | 1.27e-03 | 33 | 33 | 2 | GO:0150146 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.61e-03 | 1442 | 33 | 8 | GO:0072359 | |
| GeneOntologyBiologicalProcess | replacement ossification | 2.15e-03 | 43 | 33 | 2 | GO:0036075 | |
| GeneOntologyBiologicalProcess | endochondral ossification | 2.15e-03 | 43 | 33 | 2 | GO:0001958 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 2.15e-03 | 43 | 33 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 2.25e-03 | 44 | 33 | 2 | GO:0006958 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 C1QTNF3 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 1.93e-66 | 88 | 34 | 29 | GO:0005581 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 1.18e-39 | 530 | 34 | 28 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 5.16e-37 | 656 | 34 | 28 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 5.63e-37 | 658 | 34 | 28 | GO:0030312 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 3.26e-36 | 332 | 34 | 24 | GO:0005788 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL7A1 COL10A1 COL11A2 COL28A1 COL27A1 | 8.05e-33 | 21 | 34 | 13 | GO:0098644 |
| GeneOntologyCellularComponent | basement membrane | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL7A1 COL28A1 | 3.95e-21 | 122 | 34 | 13 | GO:0005604 |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.24e-19 | 8 | 34 | 7 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.24e-19 | 8 | 34 | 7 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.16e-17 | 6 | 34 | 6 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.24e-16 | 8 | 34 | 6 | GO:0098651 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 6.57e-12 | 12 | 34 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 6.57e-12 | 12 | 34 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL6A3 COL10A1 COL11A2 COL28A1 COL27A1 | 1.60e-09 | 1187 | 34 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type XI trimer | 3.92e-08 | 5 | 34 | 3 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen type VI trimer | 7.70e-06 | 3 | 34 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 7.70e-06 | 3 | 34 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | complement component C1q complex | 7.70e-06 | 3 | 34 | 2 | GO:0062167 | |
| GeneOntologyCellularComponent | complement component C1 complex | 7.70e-06 | 3 | 34 | 2 | GO:0005602 | |
| GeneOntologyCellularComponent | collagen type V trimer | 1.54e-05 | 4 | 34 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 3.87e-04 | 18 | 34 | 2 | GO:0098888 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 5.81e-04 | 22 | 34 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 1.48e-03 | 35 | 34 | 2 | GO:0099243 | |
| GeneOntologyCellularComponent | supramolecular fiber | 2.51e-03 | 1179 | 34 | 7 | GO:0099512 | |
| GeneOntologyCellularComponent | sarcolemma | 3.59e-03 | 190 | 34 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.09e-02 | 137 | 34 | 2 | GO:0019897 | |
| HumanPheno | Lenticonus | 2.86e-08 | 10 | 19 | 4 | HP:0001142 | |
| HumanPheno | Cigarette-paper scars | 2.86e-08 | 10 | 19 | 4 | HP:0001073 | |
| HumanPheno | Lumbar hyperlordosis | 3.52e-08 | 99 | 19 | 7 | HP:0002938 | |
| HumanPheno | Glomerular basement membrane lamellation | 4.40e-08 | 3 | 19 | 3 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 4.40e-08 | 3 | 19 | 3 | HP:0011501 | |
| HumanPheno | Atrophic scars | 1.65e-07 | 37 | 19 | 5 | HP:0001075 | |
| HumanPheno | Reduced muscle collagen VI | 1.76e-07 | 4 | 19 | 3 | HP:0030095 | |
| HumanPheno | Curved toe phalanx | 1.76e-07 | 4 | 19 | 3 | HP:0010176 | |
| HumanPheno | Reduced maximal expiratory pressure | 1.76e-07 | 4 | 19 | 3 | HP:0012497 | |
| HumanPheno | Abnormality of lens shape | 4.09e-07 | 18 | 19 | 4 | HP:0011526 | |
| HumanPheno | Increased laxity of fingers | 4.38e-07 | 5 | 19 | 3 | HP:0006149 | |
| HumanPheno | Glomerular deposits | 6.45e-07 | 20 | 19 | 4 | HP:0030949 | |
| HumanPheno | Abnormality of the wrist | 1.35e-06 | 168 | 19 | 7 | HP:0003019 | |
| HumanPheno | Wrist hypermobility | 1.53e-06 | 7 | 19 | 3 | HP:0005072 | |
| HumanPheno | Abnormality of the elbow | 3.54e-06 | 282 | 19 | 8 | HP:0009811 | |
| HumanPheno | Atypical scarring of skin | 5.60e-06 | 74 | 19 | 5 | HP:0000987 | |
| HumanPheno | Hyperlordosis | 8.75e-06 | 222 | 19 | 7 | HP:0003307 | |
| HumanPheno | Lordosis | 8.75e-06 | 222 | 19 | 7 | HP:0002939 | |
| HumanPheno | Wrist flexion contracture | 9.42e-06 | 38 | 19 | 4 | HP:0001239 | |
| HumanPheno | Thickened glomerular basement membrane | 9.48e-06 | 12 | 19 | 3 | HP:0004722 | |
| HumanPheno | Myopia | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL18A1 COL11A2 | 1.18e-05 | 447 | 19 | 9 | HP:0000545 |
| HumanPheno | Abnormal glomerular basement membrane morphology | 1.23e-05 | 13 | 19 | 3 | HP:0033282 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 1.32e-05 | 2 | 19 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 1.32e-05 | 2 | 19 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 1.32e-05 | 2 | 19 | 2 | HP:0006756 | |
| HumanPheno | Glomerular subepithelial deposits | 1.56e-05 | 14 | 19 | 3 | HP:0033603 | |
| HumanPheno | Enlarged epiphyses | 1.95e-05 | 15 | 19 | 3 | HP:0010580 | |
| HumanPheno | Limited elbow movement | 2.23e-05 | 168 | 19 | 6 | HP:0002996 | |
| HumanPheno | Abnormal ankle morphology | 2.47e-05 | 100 | 19 | 5 | HP:0034673 | |
| HumanPheno | Hip dislocation | 2.66e-05 | 263 | 19 | 7 | HP:0002827 | |
| HumanPheno | Scarring | 2.71e-05 | 102 | 19 | 5 | HP:0100699 | |
| HumanPheno | Diaphragmatic weakness | 2.90e-05 | 17 | 19 | 3 | HP:0009113 | |
| HumanPheno | Finger joint hypermobility | 3.34e-05 | 52 | 19 | 4 | HP:0006094 | |
| HumanPheno | Dermal atrophy | 3.42e-05 | 107 | 19 | 5 | HP:0004334 | |
| HumanPheno | Vulvar neoplasm | 3.95e-05 | 3 | 19 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 3.95e-05 | 3 | 19 | 2 | HP:0032141 | |
| HumanPheno | Thin glomerular basement membrane | 3.95e-05 | 3 | 19 | 2 | HP:0012577 | |
| HumanPheno | Joint laxity | 4.18e-05 | 55 | 19 | 4 | HP:0001388 | |
| HumanPheno | Abnormal urine cytology | 4.24e-05 | 188 | 19 | 6 | HP:0012614 | |
| HumanPheno | Hematuria | 4.24e-05 | 188 | 19 | 6 | HP:0000790 | |
| HumanPheno | Ankle flexion contracture | 4.49e-05 | 56 | 19 | 4 | HP:0006466 | |
| HumanPheno | Abnormal lens morphology | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL18A1 COL7A1 COL11A2 COL25A1 | 4.66e-05 | 837 | 19 | 11 | HP:0000517 |
| HumanPheno | Metaphyseal cupping | 4.82e-05 | 20 | 19 | 3 | HP:0003021 | |
| HumanPheno | Abnormality of hand joint mobility | 4.82e-05 | 57 | 19 | 4 | HP:0006256 | |
| HumanPheno | Spinal rigidity | 5.53e-05 | 59 | 19 | 4 | HP:0003306 | |
| HumanPheno | Ankle contracture | 5.91e-05 | 60 | 19 | 4 | HP:0034677 | |
| HumanPheno | Vitreoretinopathy | 6.48e-05 | 22 | 19 | 3 | HP:0007773 | |
| HumanPheno | Hip contracture | 6.73e-05 | 62 | 19 | 4 | HP:0003273 | |
| HumanPheno | Abnormality of refraction | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL18A1 COL11A2 COL25A1 | 7.21e-05 | 709 | 19 | 10 | HP:0000539 |
| HumanPheno | Quadriceps muscle weakness | 7.43e-05 | 23 | 19 | 3 | HP:0003731 | |
| HumanPheno | short, dumbbell appearance of long bones | 7.87e-05 | 4 | 19 | 2 | HP:0005061 | |
| HumanPheno | Dumbbell-shaped femur | 7.87e-05 | 4 | 19 | 2 | HP:0006375 | |
| HumanPheno | Pretibial blistering | 7.87e-05 | 4 | 19 | 2 | HP:0012221 | |
| HumanPheno | Short tubular bones of the hand | 7.87e-05 | 4 | 19 | 2 | HP:0001248 | |
| HumanPheno | Waddling gait | 8.74e-05 | 130 | 19 | 5 | HP:0002515 | |
| HumanPheno | Lower extremity joint dislocation | 9.07e-05 | 318 | 19 | 7 | HP:0030311 | |
| HumanPheno | Abnormal corneal epithelium morphology | 9.40e-05 | 132 | 19 | 5 | HP:0011495 | |
| HumanPheno | Small joint hypermobilty | 1.03e-04 | 69 | 19 | 4 | HP:0430046 | |
| HumanPheno | Progressive proximal muscle weakness | 1.22e-04 | 27 | 19 | 3 | HP:0009073 | |
| HumanPheno | Nephritis | 1.29e-04 | 141 | 19 | 5 | HP:0000123 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.31e-04 | 5 | 19 | 2 | HP:0007964 | |
| HumanPheno | Cupped ribs | 1.51e-04 | 29 | 19 | 3 | HP:0000887 | |
| HumanPheno | Limited hip movement | 1.66e-04 | 78 | 19 | 4 | HP:0008800 | |
| HumanPheno | Muscular dystrophy | 1.83e-04 | 80 | 19 | 4 | HP:0003560 | |
| HumanPheno | Abnormal hip joint morphology | 2.01e-04 | 490 | 19 | 8 | HP:0001384 | |
| HumanPheno | Abnormality of the knee | 2.04e-04 | 491 | 19 | 8 | HP:0002815 | |
| HumanPheno | Abnormal muscle fiber protein expression | 2.04e-04 | 32 | 19 | 3 | HP:0030089 | |
| HumanPheno | Increased endomysial connective tissue | 2.04e-04 | 32 | 19 | 3 | HP:0100297 | |
| HumanPheno | Abnormal knee morphology | 2.13e-04 | 364 | 19 | 7 | HP:0034669 | |
| HumanPheno | Esophageal stenosis | 2.24e-04 | 33 | 19 | 3 | HP:0010450 | |
| HumanPheno | Abnormal synovial membrane morphology | 2.41e-04 | 503 | 19 | 8 | HP:0005262 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL5A1 COL6A1 COL6A2 COL6A3 COL10A1 COL11A2 COL25A1 COL27A1 | 2.47e-04 | 653 | 19 | 9 | HP:0003272 |
| HumanPheno | Torticollis | 2.53e-04 | 87 | 19 | 4 | HP:0000473 | |
| HumanPheno | Cataract | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL18A1 COL7A1 COL11A2 COL25A1 | 2.59e-04 | 822 | 19 | 10 | HP:0000518 |
| HumanPheno | Irregular acetabular roof | 2.74e-04 | 7 | 19 | 2 | HP:0008833 | |
| HumanPheno | Dumbbell-shaped long bone | 2.74e-04 | 7 | 19 | 2 | HP:0000947 | |
| HumanPheno | Keratosis pilaris | 3.16e-04 | 37 | 19 | 3 | HP:0032152 | |
| HumanPheno | Joint dislocation | 3.28e-04 | 390 | 19 | 7 | HP:0001373 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 3.64e-04 | 8 | 19 | 2 | HP:0003262 | |
| HumanPheno | Elbow flexion contracture | 3.85e-04 | 97 | 19 | 4 | HP:0002987 | |
| HumanPheno | Heterotropia | 3.94e-04 | 281 | 19 | 6 | HP:0032012 | |
| HumanPheno | Increased muscle lipid content | 3.98e-04 | 40 | 19 | 3 | HP:0009058 | |
| HumanPheno | Lower-limb joint contracture | 4.01e-04 | 403 | 19 | 7 | HP:0005750 | |
| HumanPheno | Abnormal scapula morphology | 4.15e-04 | 181 | 19 | 5 | HP:0000782 | |
| HumanPheno | Tibial bowing | 4.29e-04 | 41 | 19 | 3 | HP:0002982 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 4.33e-04 | 547 | 19 | 8 | HP:0100239 | |
| HumanPheno | Abnormality of upper limb joint | COL2A1 COL5A1 COL6A1 COL6A2 COL6A3 COL7A1 COL11A2 COL25A1 COL27A1 | 4.46e-04 | 705 | 19 | 9 | HP:0009810 |
| HumanPheno | Distal joint hypermobility | 4.67e-04 | 9 | 19 | 2 | HP:0020152 | |
| HumanPheno | Lens dislocation | 4.94e-04 | 43 | 19 | 3 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 4.94e-04 | 43 | 19 | 3 | HP:0001083 | |
| HumanPheno | Knee flexion contracture | 5.21e-04 | 105 | 19 | 4 | HP:0006380 | |
| HumanPheno | Abnormality of the ankle | 5.45e-04 | 192 | 19 | 5 | HP:0003028 | |
| HumanPheno | Chronic kidney disease | 5.72e-04 | 194 | 19 | 5 | HP:0012622 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 COL5A1 COL6A1 COL6A2 COL6A3 COL10A1 COL11A2 COL25A1 COL27A1 | 5.82e-04 | 730 | 19 | 9 | HP:0002644 |
| HumanPheno | Abnormal ulnar metaphysis morphology | 5.83e-04 | 10 | 19 | 2 | HP:0004039 | |
| HumanPheno | Schizencephaly | 5.83e-04 | 10 | 19 | 2 | HP:0010636 | |
| HumanPheno | Vaginal neoplasm | 5.83e-04 | 10 | 19 | 2 | HP:0100650 | |
| HumanPheno | Elbow contracture | 6.00e-04 | 109 | 19 | 4 | HP:0034391 | |
| HumanPheno | Rimmed vacuoles | 6.04e-04 | 46 | 19 | 3 | HP:0003805 | |
| HumanPheno | Limitation of joint mobility | 6.15e-04 | 432 | 19 | 7 | HP:0001376 | |
| MousePheno | podocyte foot process effacement | 1.06e-08 | 38 | 28 | 5 | MP:0008140 | |
| MousePheno | hematuria | 4.89e-08 | 19 | 28 | 4 | MP:0005161 | |
| MousePheno | abnormal podocyte foot process morphology | 7.18e-08 | 55 | 28 | 5 | MP:0008059 | |
| MousePheno | abnormal podocyte morphology | 2.45e-07 | 70 | 28 | 5 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 2.45e-07 | 70 | 28 | 5 | MP:0011497 | |
| MousePheno | abnormal glomerular mesangium morphology | 5.77e-07 | 83 | 28 | 5 | MP:0011339 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 1.65e-06 | 44 | 28 | 4 | MP:0011348 | |
| MousePheno | expanded mesangial matrix | 1.98e-06 | 46 | 28 | 4 | MP:0011353 | |
| MousePheno | abnormal renal glomerular capsule morphology | 2.04e-06 | 107 | 28 | 5 | MP:0002828 | |
| MousePheno | abnormal mesangial matrix morphology | 3.02e-06 | 51 | 28 | 4 | MP:0011338 | |
| MousePheno | glomerular crescent | 6.83e-06 | 19 | 28 | 3 | MP:0011506 | |
| MousePheno | albuminuria | 7.07e-06 | 63 | 28 | 4 | MP:0002871 | |
| MousePheno | abnormal renal glomerulus morphology | 1.14e-05 | 264 | 28 | 6 | MP:0005325 | |
| MousePheno | kidney inflammation | 2.02e-05 | 171 | 28 | 5 | MP:0001859 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 2.04e-05 | 27 | 28 | 3 | MP:0011409 | |
| MousePheno | abnormal renal corpuscle morphology | 2.06e-05 | 293 | 28 | 6 | MP:0002827 | |
| MousePheno | abnormal chondrocyte morphology | 2.12e-05 | 83 | 28 | 4 | MP:0000166 | |
| MousePheno | subarachnoid hemorrhage | 2.32e-05 | 4 | 28 | 2 | MP:0031109 | |
| MousePheno | buphthalmos | 2.32e-05 | 4 | 28 | 2 | MP:0009274 | |
| MousePheno | renal/urinary system inflammation | 2.59e-05 | 180 | 28 | 5 | MP:0011762 | |
| MousePheno | renal tubule atrophy | 2.82e-05 | 30 | 28 | 3 | MP:0011346 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 3.12e-05 | 31 | 28 | 3 | MP:0011349 | |
| MousePheno | abnormal kidney cortex morphology | 3.62e-05 | 324 | 28 | 6 | MP:0000521 | |
| MousePheno | pale kidney | 3.77e-05 | 33 | 28 | 3 | MP:0004969 | |
| MousePheno | renal glomerular synechia | 3.85e-05 | 5 | 28 | 2 | MP:0011483 | |
| MousePheno | anterior polar cataract | 3.85e-05 | 5 | 28 | 2 | MP:0010259 | |
| MousePheno | renal cast | 4.13e-05 | 34 | 28 | 3 | MP:0011402 | |
| MousePheno | abnormal lens morphology | 4.78e-05 | 699 | 28 | 8 | MP:0001303 | |
| MousePheno | sensorineural hearing loss | 5.34e-05 | 37 | 28 | 3 | MP:0004740 | |
| MousePheno | polar cataract | 5.77e-05 | 6 | 28 | 2 | MP:0010258 | |
| MousePheno | sensorineural hearing impairment | 5.79e-05 | 38 | 28 | 3 | MP:0006329 | |
| MousePheno | irregularly shaped pupil | 6.27e-05 | 39 | 28 | 3 | MP:0001319 | |
| MousePheno | abnormal basement membrane morphology | 6.77e-05 | 40 | 28 | 3 | MP:0004272 | |
| MousePheno | abnormal kidney physiology | 7.82e-05 | 372 | 28 | 6 | MP:0002136 | |
| MousePheno | abnormal renal tubule morphology | 7.83e-05 | 227 | 28 | 5 | MP:0002703 | |
| MousePheno | retrognathia | 8.07e-05 | 7 | 28 | 2 | MP:0004282 | |
| MousePheno | macrophthalmia | 1.08e-04 | 8 | 28 | 2 | MP:0001296 | |
| MousePheno | prominent forehead | 1.08e-04 | 8 | 28 | 2 | MP:0030049 | |
| MousePheno | abnormal glomerular capillary morphology | 1.10e-04 | 47 | 28 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 1.17e-04 | 48 | 28 | 3 | MP:0011310 | |
| MousePheno | dilated glomerular capillary | 1.38e-04 | 9 | 28 | 2 | MP:0011509 | |
| MousePheno | kidney atrophy | 1.58e-04 | 53 | 28 | 3 | MP:0004970 | |
| MousePheno | abnormal nephron morphology | 1.65e-04 | 426 | 28 | 6 | MP:0003881 | |
| MousePheno | myopathy | 1.67e-04 | 54 | 28 | 3 | MP:0000751 | |
| MousePheno | renal interstitial fibrosis | 1.67e-04 | 54 | 28 | 3 | MP:0003215 | |
| MousePheno | increased urine protein level | 2.08e-04 | 149 | 28 | 4 | MP:0002962 | |
| MousePheno | cortical renal glomerulopathies | 2.48e-04 | 156 | 28 | 4 | MP:0000523 | |
| MousePheno | dilated capillary | 2.98e-04 | 13 | 28 | 2 | MP:0020326 | |
| MousePheno | total cataract | 2.98e-04 | 13 | 28 | 2 | MP:0010263 | |
| MousePheno | abnormal kidney interstitium morphology | 3.16e-04 | 67 | 28 | 3 | MP:0011425 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 3.31e-04 | 68 | 28 | 3 | MP:0003662 | |
| MousePheno | glomerulosclerosis | 3.31e-04 | 68 | 28 | 3 | MP:0005264 | |
| MousePheno | abnormal urine protein level | 3.44e-04 | 170 | 28 | 4 | MP:0006315 | |
| MousePheno | abnormal articular cartilage morphology | 3.47e-04 | 14 | 28 | 2 | MP:0006433 | |
| MousePheno | kidney hemorrhage | 3.47e-04 | 14 | 28 | 2 | MP:0000533 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | 3.60e-04 | 172 | 28 | 4 | MP:0003055 | |
| MousePheno | abnormal kidney vasculature morphology | 4.08e-04 | 73 | 28 | 3 | MP:0000530 | |
| MousePheno | abnormal epiphyseal plate morphology | 4.74e-04 | 185 | 28 | 4 | MP:0006395 | |
| MousePheno | renal fibrosis | 4.95e-04 | 78 | 28 | 3 | MP:0003985 | |
| MousePheno | abnormal forehead shape | 5.16e-04 | 17 | 28 | 2 | MP:0030045 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 5.33e-04 | 80 | 28 | 3 | MP:0009404 | |
| MousePheno | chondrodystrophy | 5.80e-04 | 18 | 28 | 2 | MP:0002657 | |
| MousePheno | abnormal anterior uvea morphology | 6.24e-04 | 199 | 28 | 4 | MP:0005194 | |
| MousePheno | abnormal pupil morphology | 6.37e-04 | 85 | 28 | 3 | MP:0001317 | |
| MousePheno | lens vacuoles | 7.19e-04 | 20 | 28 | 2 | MP:0011697 | |
| MousePheno | abnormal lens capsule morphology | 7.19e-04 | 20 | 28 | 2 | MP:0003236 | |
| MousePheno | polyuria | 7.28e-04 | 89 | 28 | 3 | MP:0001762 | |
| MousePheno | decreased grip strength | 8.19e-04 | 575 | 28 | 6 | MP:0010053 | |
| MousePheno | abnormal capillary morphology | 8.28e-04 | 93 | 28 | 3 | MP:0003658 | |
| MousePheno | abnormal blood urea nitrogen level | 9.42e-04 | 389 | 28 | 5 | MP:0005265 | |
| MousePheno | impaired hearing | 9.55e-04 | 223 | 28 | 4 | MP:0006325 | |
| MousePheno | abnormal extracellular matrix morphology | 1.02e-03 | 100 | 28 | 3 | MP:0013258 | |
| MousePheno | lethargy | 1.02e-03 | 100 | 28 | 3 | MP:0005202 | |
| MousePheno | abnormal alertness | 1.02e-03 | 100 | 28 | 3 | MP:0020222 | |
| MousePheno | decreased alertness | 1.02e-03 | 100 | 28 | 3 | MP:0020224 | |
| MousePheno | tubulointerstitial nephritis | 1.04e-03 | 24 | 28 | 2 | MP:0011405 | |
| MousePheno | abnormal ciliary body morphology | 1.04e-03 | 24 | 28 | 2 | MP:0005099 | |
| MousePheno | abnormal forehead morphology | 1.04e-03 | 24 | 28 | 2 | MP:0030031 | |
| MousePheno | dilated renal tubule | 1.05e-03 | 101 | 28 | 3 | MP:0002705 | |
| MousePheno | increased circulating creatinine level | 1.05e-03 | 229 | 28 | 4 | MP:0005553 | |
| MousePheno | abnormal blood circulation | 1.11e-03 | 845 | 28 | 7 | MP:0002128 | |
| MousePheno | disorganized long bone epiphyseal plate | 1.13e-03 | 25 | 28 | 2 | MP:0006397 | |
| MousePheno | abnormal anterior eye segment morphology | 1.18e-03 | 1117 | 28 | 8 | MP:0005193 | |
| MousePheno | abnormal uvea morphology | 1.27e-03 | 241 | 28 | 4 | MP:0005197 | |
| MousePheno | skeletal muscle fibrosis | 1.42e-03 | 28 | 28 | 2 | MP:0009419 | |
| MousePheno | increased mesangial cell number | 1.52e-03 | 29 | 28 | 2 | MP:0011427 | |
| MousePheno | uremia | 1.58e-03 | 437 | 28 | 5 | MP:0009644 | |
| MousePheno | hemorrhage | 1.73e-03 | 664 | 28 | 6 | MP:0001914 | |
| MousePheno | abnormal synovial joint morphology | 1.90e-03 | 124 | 28 | 3 | MP:0030804 | |
| MousePheno | abnormal circulating total protein level | 1.91e-03 | 269 | 28 | 4 | MP:0011888 | |
| MousePheno | abnormal grip strength | 2.14e-03 | 946 | 28 | 7 | MP:0001515 | |
| MousePheno | abnormal renal/urinary system physiology | 2.18e-03 | 695 | 28 | 6 | MP:0005502 | |
| MousePheno | decreased hemoglobin content | 2.32e-03 | 284 | 28 | 4 | MP:0002874 | |
| MousePheno | abnormal eye development | 2.43e-03 | 482 | 28 | 5 | MP:0001286 | |
| MousePheno | increased blood urea nitrogen level | 2.48e-03 | 289 | 28 | 4 | MP:0005565 | |
| MousePheno | abnormal mesangial cell morphology | 2.60e-03 | 38 | 28 | 2 | MP:0005327 | |
| Domain | Collagen | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 C1QTNF3 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 1.51e-65 | 85 | 34 | 29 | PF01391 |
| Domain | Collagen | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 C1QTNF3 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 1.51e-65 | 85 | 34 | 29 | IPR008160 |
| Domain | TSPN | COL5A1 COL18A1 COL24A1 COL22A1 COL11A2 COL16A1 COL19A1 COL21A1 COL27A1 | 5.54e-20 | 23 | 34 | 9 | SM00210 |
| Domain | C4 | 2.28e-17 | 6 | 34 | 6 | SM00111 | |
| Domain | - | 2.28e-17 | 6 | 34 | 6 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.28e-17 | 6 | 34 | 6 | IPR001442 | |
| Domain | NC1_IV | 2.28e-17 | 6 | 34 | 6 | PS51403 | |
| Domain | C4 | 2.28e-17 | 6 | 34 | 6 | PF01413 | |
| Domain | Laminin_G | COL5A1 COL18A1 COL24A1 COL22A1 COL11A2 COL16A1 COL19A1 COL21A1 COL27A1 | 6.92e-16 | 58 | 34 | 9 | IPR001791 |
| Domain | Fib_collagen_C | 6.74e-12 | 11 | 34 | 5 | IPR000885 | |
| Domain | NC1_FIB | 6.74e-12 | 11 | 34 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 6.74e-12 | 11 | 34 | 5 | PD002078 | |
| Domain | COLFI | 6.74e-12 | 11 | 34 | 5 | SM00038 | |
| Domain | COLFI | 6.74e-12 | 11 | 34 | 5 | PF01410 | |
| Domain | VWA | 7.46e-12 | 56 | 34 | 7 | PF00092 | |
| Domain | - | 5.66e-11 | 74 | 34 | 7 | 3.40.50.410 | |
| Domain | VWFA | 1.18e-10 | 82 | 34 | 7 | PS50234 | |
| Domain | VWA | 1.41e-10 | 84 | 34 | 7 | SM00327 | |
| Domain | ConA-like_dom | COL5A1 COL18A1 COL24A1 COL22A1 COL11A2 COL16A1 COL19A1 COL21A1 COL27A1 | 1.45e-10 | 219 | 34 | 9 | IPR013320 |
| Domain | VWF_A | 4.54e-10 | 99 | 34 | 7 | IPR002035 | |
| Domain | CTDL_fold | 7.86e-10 | 107 | 34 | 7 | IPR016187 | |
| Domain | C1Q | 2.86e-09 | 32 | 34 | 5 | SM00110 | |
| Domain | C1q | 2.86e-09 | 32 | 34 | 5 | PF00386 | |
| Domain | C1q_dom | 3.94e-09 | 34 | 34 | 5 | IPR001073 | |
| Domain | C1Q | 3.94e-09 | 34 | 34 | 5 | PS50871 | |
| Domain | - | 1.77e-08 | 95 | 34 | 6 | 2.60.120.200 | |
| Domain | - | 2.94e-08 | 50 | 34 | 5 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 6.29e-08 | 58 | 34 | 5 | IPR008983 | |
| Domain | - | 4.41e-06 | 18 | 34 | 3 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 4.41e-06 | 18 | 34 | 3 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 5.24e-06 | 19 | 34 | 3 | PS50279 | |
| Domain | BPTI_KUNITZ_1 | 5.24e-06 | 19 | 34 | 3 | PS00280 | |
| Domain | Kunitz_BPTI | 5.24e-06 | 19 | 34 | 3 | PF00014 | |
| Domain | Kunitz_BPTI | 9.52e-06 | 23 | 34 | 3 | IPR002223 | |
| Domain | LAM_G_DOMAIN | 4.45e-05 | 38 | 34 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 5.20e-05 | 40 | 34 | 3 | PF02210 | |
| Domain | LamG | 6.94e-05 | 44 | 34 | 3 | SM00282 | |
| Domain | KU | 4.83e-04 | 18 | 34 | 2 | SM00131 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 3.46e-59 | 44 | 29 | 24 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 1.90e-53 | 67 | 29 | 24 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 4.38e-50 | 41 | 29 | 21 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 8.52e-50 | 90 | 29 | 24 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.96e-45 | 61 | 29 | 21 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 4.64e-43 | 76 | 29 | 21 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL16A1 COL25A1 COL19A1 | 3.06e-39 | 64 | 29 | 19 | M26953 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 3.19e-36 | 300 | 29 | 24 | M610 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL25A1 COL19A1 | 1.71e-35 | 53 | 29 | 17 | MM14566 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL27A1 | 2.82e-34 | 61 | 29 | 17 | M27103 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL16A1 COL25A1 COL19A1 | 4.56e-32 | 140 | 29 | 19 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 5.39e-31 | 258 | 29 | 21 | MM14572 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 | 1.29e-30 | 50 | 29 | 15 | MM14796 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL25A1 COL19A1 | 3.74e-29 | 114 | 29 | 17 | MM14571 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL16A1 | 4.36e-29 | 85 | 29 | 16 | M16441 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL16A1 | 1.29e-28 | 46 | 29 | 14 | M198 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL7A1 COL10A1 COL11A2 COL16A1 | 2.39e-25 | 74 | 29 | 14 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL16A1 | 3.59e-25 | 76 | 29 | 14 | MM14867 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL11A2 | 9.46e-24 | 66 | 29 | 13 | M18 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 4.29e-23 | 20 | 29 | 10 | MM15061 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL10A1 COL11A2 | 1.48e-20 | 32 | 29 | 10 | MM14924 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 1.07e-19 | 38 | 29 | 10 | MM14969 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 3.33e-19 | 42 | 29 | 10 | M7169 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 | 1.68e-18 | 76 | 29 | 11 | M27219 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 9.59e-18 | 57 | 29 | 10 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 1.16e-17 | 58 | 29 | 10 | M2049 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL10A1 COL11A2 | 1.39e-17 | 59 | 29 | 10 | M27218 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 2.82e-17 | 63 | 29 | 10 | M11187 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.53e-16 | 15 | 29 | 7 | M27161 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL11A2 | 5.93e-16 | 84 | 29 | 10 | M7098 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.32e-16 | 30 | 29 | 8 | M27216 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 9.11e-15 | 10 | 29 | 6 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 9.11e-15 | 10 | 29 | 6 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.00e-14 | 11 | 29 | 6 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.00e-14 | 12 | 29 | 6 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.41e-14 | 13 | 29 | 6 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 7.41e-14 | 13 | 29 | 6 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.30e-13 | 14 | 29 | 6 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.30e-13 | 14 | 29 | 6 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.16e-13 | 15 | 29 | 6 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.96e-13 | 18 | 29 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.96e-13 | 18 | 29 | 6 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.66e-12 | 20 | 29 | 6 | M15394 | |
| Pathway | KEGG_FOCAL_ADHESION | COL2A1 COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL11A2 | 3.97e-12 | 199 | 29 | 10 | M7253 |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.30e-12 | 23 | 29 | 6 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.30e-12 | 23 | 29 | 6 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL24A1 COL6A2 COL6A3 COL11A2 COL27A1 | 1.06e-11 | 532 | 29 | 13 | M27870 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 5.86e-11 | 261 | 29 | 10 | MM15676 |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.53e-10 | 43 | 29 | 6 | M39565 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 COL11A2 | 2.92e-10 | 418 | 29 | 11 | MM15587 |
| Pathway | WP_PI3KAKT_SIGNALING | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL6A1 COL6A2 COL6A3 | 7.56e-10 | 339 | 29 | 10 | M39736 |
| Pathway | WP_FOCAL_ADHESION | 2.79e-09 | 187 | 29 | 8 | MM15913 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.52e-09 | 30 | 29 | 5 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.82e-08 | 41 | 29 | 5 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.34e-08 | 43 | 29 | 5 | M53 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 3.27e-08 | 502 | 29 | 10 | MM14537 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.56e-08 | 96 | 29 | 6 | M39834 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.70e-08 | 47 | 29 | 5 | MM14925 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 1.17e-07 | 575 | 29 | 10 | M29853 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.17e-07 | 302 | 29 | 8 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.11e-07 | 326 | 29 | 8 | MM15917 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.20e-07 | 79 | 29 | 5 | M27643 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 7.73e-07 | 161 | 29 | 6 | M39770 | |
| Pathway | WP_FOCAL_ADHESION | 2.66e-06 | 199 | 29 | 6 | M39402 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.42e-06 | 19 | 29 | 3 | MM15512 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.49e-05 | 84 | 29 | 4 | M3228 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.06e-05 | 30 | 29 | 3 | MM15517 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE | 6.10e-05 | 6 | 29 | 2 | M47783 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.05e-04 | 45 | 29 | 3 | M39864 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.14e-04 | 8 | 29 | 2 | M47872 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.81e-04 | 54 | 29 | 3 | MM14655 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 2.28e-04 | 439 | 29 | 6 | M42563 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.43e-04 | 67 | 29 | 3 | MM15345 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 | 3.71e-04 | 1432 | 29 | 10 | M509 |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 4.07e-04 | 71 | 29 | 3 | M1078 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 4.22e-04 | 15 | 29 | 2 | M7146 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.24e-04 | 72 | 29 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.42e-04 | 73 | 29 | 3 | MM15906 | |
| Pathway | WP_CANCER_PATHWAYS | 4.93e-04 | 507 | 29 | 6 | M48302 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 5.45e-04 | 17 | 29 | 2 | MM15944 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 5.78e-04 | 80 | 29 | 3 | M6121 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 6.67e-04 | 84 | 29 | 3 | MM14653 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 6.84e-04 | 19 | 29 | 2 | M27221 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 7.59e-04 | 20 | 29 | 2 | M917 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 7.89e-04 | 89 | 29 | 3 | M39398 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 9.20e-04 | 22 | 29 | 2 | M39502 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.31e-03 | 106 | 29 | 3 | M42535 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.66e-03 | 115 | 29 | 3 | M19752 | |
| Pathway | KEGG_PRION_DISEASES | 2.33e-03 | 35 | 29 | 2 | M13036 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 2.89e-03 | 39 | 29 | 2 | MM17212 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 3.04e-03 | 40 | 29 | 2 | M39340 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 3.04e-03 | 40 | 29 | 2 | M39695 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 3.34e-03 | 42 | 29 | 2 | MM15945 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 4.00e-03 | 46 | 29 | 2 | MM15837 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.18e-03 | 325 | 29 | 4 | M12868 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 4.71e-03 | 50 | 29 | 2 | M48087 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 6.29e-03 | 58 | 29 | 2 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 6.50e-03 | 59 | 29 | 2 | M48343 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 7.38e-03 | 63 | 29 | 2 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 7.38e-03 | 63 | 29 | 2 | M39646 | |
| Pubmed | COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 | 6.22e-39 | 153 | 35 | 20 | 25037231 | |
| Pubmed | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL28A1 COL27A1 | 1.07e-37 | 175 | 35 | 20 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL11A2 COL16A1 COL21A1 COL28A1 | 1.60e-37 | 135 | 35 | 19 | 28675934 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 C1QC COL6A2 COL7A1 COL10A1 COL11A2 COL16A1 FCN1 COL27A1 | 2.93e-33 | 62 | 35 | 15 | 28344315 |
| Pubmed | COL4A1 COL23A1 COL4A2 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL16A1 COL25A1 COL28A1 COL27A1 | 3.03e-33 | 167 | 35 | 18 | 22159717 | |
| Pubmed | 4.40e-21 | 8 | 35 | 7 | 10382266 | ||
| Pubmed | 4.40e-21 | 8 | 35 | 7 | 3997552 | ||
| Pubmed | COL2A1 COL23A1 COL4A3 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL7A1 COL10A1 COL11A2 COL16A1 COL19A1 | 1.28e-20 | 210 | 35 | 13 | 16537572 | |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 6.61e-19 | 6 | 35 | 6 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 6.61e-19 | 6 | 35 | 6 | 9506531 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 6.61e-19 | 6 | 35 | 6 | 9673377 | |
| Pubmed | 6.61e-19 | 6 | 35 | 6 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 6.61e-19 | 6 | 35 | 6 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 6.61e-19 | 6 | 35 | 6 | 6811420 | |
| Pubmed | 6.61e-19 | 6 | 35 | 6 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 6.61e-19 | 6 | 35 | 6 | 19275937 | |
| Pubmed | 6.61e-19 | 6 | 35 | 6 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 6.61e-19 | 6 | 35 | 6 | 6389236 | |
| Pubmed | 6.61e-19 | 6 | 35 | 6 | 12225806 | ||
| Pubmed | 4.62e-18 | 7 | 35 | 6 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 4.62e-18 | 7 | 35 | 6 | 8006028 | |
| Pubmed | 4.62e-18 | 7 | 35 | 6 | 10416788 | ||
| Pubmed | 4.62e-18 | 7 | 35 | 6 | 1724753 | ||
| Pubmed | 1.85e-17 | 8 | 35 | 6 | 29422532 | ||
| Pubmed | 2.67e-17 | 39 | 35 | 8 | 33580754 | ||
| Pubmed | 2.75e-17 | 19 | 35 | 7 | 15689378 | ||
| Pubmed | 5.54e-17 | 9 | 35 | 6 | 9878537 | ||
| Pubmed | 5.54e-17 | 9 | 35 | 6 | 12101409 | ||
| Pubmed | 1.38e-16 | 10 | 35 | 6 | 9136074 | ||
| Pubmed | 2.31e-16 | 50 | 35 | 8 | 23658023 | ||
| Pubmed | 3.04e-16 | 11 | 35 | 6 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.04e-16 | 11 | 35 | 6 | 7500359 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | COL2A1 COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL28A1 | 4.64e-16 | 97 | 35 | 9 | 27559042 |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 6.08e-16 | 12 | 35 | 6 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 6.08e-16 | 12 | 35 | 6 | 12180907 | |
| Pubmed | 6.08e-16 | 12 | 35 | 6 | 16024816 | ||
| Pubmed | 7.66e-16 | 5 | 35 | 5 | 9409248 | ||
| Pubmed | 1.97e-15 | 14 | 35 | 6 | 12878203 | ||
| Pubmed | 4.59e-15 | 6 | 35 | 5 | 7495302 | ||
| Pubmed | 5.25e-15 | 16 | 35 | 6 | 15878328 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.10e-14 | 79 | 35 | 8 | 18757743 | |
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 1.61e-14 | 7 | 35 | 5 | 9334230 | |
| Pubmed | 1.61e-14 | 7 | 35 | 5 | 10639489 | ||
| Pubmed | 1.61e-14 | 7 | 35 | 5 | 7521231 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.61e-14 | 7 | 35 | 5 | 10716744 | |
| Pubmed | COL2A1 COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL16A1 | 2.03e-14 | 146 | 35 | 9 | 27068509 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.23e-14 | 86 | 35 | 8 | 28327460 | |
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 4.28e-14 | 8 | 35 | 5 | 10970885 | |
| Pubmed | 4.28e-14 | 8 | 35 | 5 | 1377218 | ||
| Pubmed | 9.62e-14 | 9 | 35 | 5 | 8562707 | ||
| Pubmed | 1.50e-13 | 26 | 35 | 6 | 24742657 | ||
| Pubmed | 1.92e-13 | 10 | 35 | 5 | 9415455 | ||
| Pubmed | 3.09e-13 | 29 | 35 | 6 | 22613833 | ||
| Pubmed | 3.29e-13 | 64 | 35 | 7 | 22261194 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.52e-13 | 11 | 35 | 5 | 9731539 | |
| Pubmed | 4.78e-13 | 31 | 35 | 6 | 22925884 | ||
| Pubmed | 6.03e-13 | 12 | 35 | 5 | 8918877 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 8.59e-13 | 4 | 35 | 4 | 7827955 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 9.80e-13 | 13 | 35 | 5 | 9833687 | |
| Pubmed | 1.52e-12 | 14 | 35 | 5 | 19858219 | ||
| Pubmed | 1.78e-12 | 38 | 35 | 6 | 25572963 | ||
| Pubmed | 2.28e-12 | 15 | 35 | 5 | 10625553 | ||
| Pubmed | 2.28e-12 | 15 | 35 | 5 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 2.28e-12 | 15 | 35 | 5 | 10706142 | |
| Pubmed | 2.47e-12 | 40 | 35 | 6 | 27068110 | ||
| Pubmed | Physical mapping of mouse collagen genes on chromosome 10 by high-resolution FISH. | 4.29e-12 | 5 | 35 | 4 | 11331940 | |
| Pubmed | 6.50e-12 | 18 | 35 | 5 | 9160753 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 8.87e-12 | 101 | 35 | 7 | 20551380 | |
| Pubmed | 1.29e-11 | 6 | 35 | 4 | 17876790 | ||
| Pubmed | 1.54e-11 | 21 | 35 | 5 | 23325811 | ||
| Pubmed | 1.54e-11 | 21 | 35 | 5 | 27856617 | ||
| Pubmed | 3.00e-11 | 7 | 35 | 4 | 17418794 | ||
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 6.00e-11 | 8 | 35 | 4 | 12766770 | |
| Pubmed | 6.00e-11 | 8 | 35 | 4 | 11683410 | ||
| Pubmed | 6.00e-11 | 8 | 35 | 4 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 6.00e-11 | 8 | 35 | 4 | 11867580 | |
| Pubmed | 1.08e-10 | 9 | 35 | 4 | 8900172 | ||
| Pubmed | 1.08e-10 | 9 | 35 | 4 | 10880400 | ||
| Pubmed | 1.08e-10 | 9 | 35 | 4 | 8995276 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.19e-10 | 248 | 35 | 8 | 24006456 | |
| Pubmed | 1.80e-10 | 10 | 35 | 4 | 2446864 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.80e-10 | 10 | 35 | 4 | 15345741 | |
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 2.09e-10 | 34 | 35 | 5 | 16498405 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 6.51e-10 | 98 | 35 | 6 | 21942715 | |
| Pubmed | 6.62e-10 | 186 | 35 | 7 | 20452482 | ||
| Pubmed | 6.62e-10 | 186 | 35 | 7 | 20673868 | ||
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 9.34e-10 | 3 | 35 | 3 | 25204870 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 9.34e-10 | 3 | 35 | 3 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 9.34e-10 | 3 | 35 | 3 | 15954103 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 36130833 | ||
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 9.34e-10 | 3 | 35 | 3 | 19422682 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 9.34e-10 | 3 | 35 | 3 | 38433557 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 3025878 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 7780011 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 9.34e-10 | 3 | 35 | 3 | 27859054 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 25575550 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 20301676 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 9.34e-10 | 3 | 35 | 3 | 27377778 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 17396119 | ||
| Interaction | COLGALT2 interactions | COL2A1 COL4A1 COL4A2 COL4A5 C1QA COL6A1 COL18A1 COL6A2 C1QTNF3 COL10A1 COL16A1 COL21A1 FCN1 | 2.45e-24 | 67 | 35 | 13 | int:COLGALT2 |
| Interaction | MMP9 interactions | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 | 9.06e-20 | 67 | 35 | 11 | int:MMP9 |
| Interaction | LAIR2 interactions | COL2A1 COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 | 4.75e-19 | 49 | 35 | 10 | int:LAIR2 |
| Interaction | C1QC interactions | 2.01e-17 | 42 | 35 | 9 | int:C1QC | |
| Interaction | PLOD1 interactions | COL2A1 COL4A1 COL23A1 COL4A2 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL16A1 COL25A1 COL21A1 | 2.32e-17 | 292 | 35 | 14 | int:PLOD1 |
| Interaction | C1QTNF1 interactions | COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL21A1 | 6.10e-17 | 47 | 35 | 9 | int:C1QTNF1 |
| Interaction | MMP2 interactions | COL2A1 COL4A1 COL4A2 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 | 2.22e-16 | 87 | 35 | 10 | int:MMP2 |
| Interaction | COL8A2 interactions | 3.96e-15 | 42 | 35 | 8 | int:COL8A2 | |
| Interaction | DCN interactions | 4.86e-15 | 43 | 35 | 8 | int:DCN | |
| Interaction | HABP2 interactions | 3.19e-13 | 18 | 35 | 6 | int:HABP2 | |
| Interaction | PLOD3 interactions | COL4A1 COL23A1 COL4A2 C1QA COL4A6 COL6A1 COL18A1 COL6A2 COL16A1 COL21A1 | 4.49e-13 | 183 | 35 | 10 | int:PLOD3 |
| Interaction | OSM interactions | 6.65e-13 | 20 | 35 | 6 | int:OSM | |
| Interaction | CD93 interactions | 1.09e-12 | 45 | 35 | 7 | int:CD93 | |
| Interaction | FBLN2 interactions | 1.82e-11 | 66 | 35 | 7 | int:FBLN2 | |
| Interaction | SERPINE2 interactions | 5.33e-10 | 56 | 35 | 6 | int:SERPINE2 | |
| Interaction | TGFBI interactions | 6.08e-10 | 25 | 35 | 5 | int:TGFBI | |
| Interaction | COL2A1 interactions | 1.22e-09 | 64 | 35 | 6 | int:COL2A1 | |
| Interaction | BGN interactions | 1.62e-09 | 30 | 35 | 5 | int:BGN | |
| Interaction | COL4A2 interactions | 3.23e-09 | 75 | 35 | 6 | int:COL4A2 | |
| Interaction | C1QTNF9 interactions | 4.91e-09 | 37 | 35 | 5 | int:C1QTNF9 | |
| Interaction | COL9A1 interactions | 5.39e-09 | 13 | 35 | 4 | int:COL9A1 | |
| Interaction | COL4A1 interactions | 1.90e-08 | 48 | 35 | 5 | int:COL4A1 | |
| Interaction | MATN2 interactions | 3.86e-08 | 113 | 35 | 6 | int:MATN2 | |
| Interaction | C1QTNF2 interactions | 7.07e-08 | 62 | 35 | 5 | int:C1QTNF2 | |
| Interaction | THBS1 interactions | 7.77e-08 | 127 | 35 | 6 | int:THBS1 | |
| Interaction | FN1 interactions | COL2A1 COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 C1QC COL6A2 COL7A1 | 1.13e-07 | 848 | 35 | 11 | int:FN1 |
| Interaction | ANTXR2 interactions | 1.76e-07 | 29 | 35 | 4 | int:ANTXR2 | |
| Interaction | MAG interactions | 1.76e-07 | 29 | 35 | 4 | int:MAG | |
| Interaction | PDGFA interactions | 2.65e-07 | 32 | 35 | 4 | int:PDGFA | |
| Interaction | COLQ interactions | 3.01e-07 | 33 | 35 | 4 | int:COLQ | |
| Interaction | C1QB interactions | 5.76e-07 | 94 | 35 | 5 | int:C1QB | |
| Interaction | PLOD2 interactions | 6.11e-07 | 180 | 35 | 6 | int:PLOD2 | |
| Interaction | C1QTNF9B interactions | 1.80e-06 | 51 | 35 | 4 | int:C1QTNF9B | |
| Interaction | SAA1 interactions | 2.27e-06 | 54 | 35 | 4 | int:SAA1 | |
| Interaction | COL16A1 interactions | 3.85e-06 | 18 | 35 | 3 | int:COL16A1 | |
| Interaction | P4HA1 interactions | 1.12e-05 | 298 | 35 | 6 | int:P4HA1 | |
| Interaction | PDGFB interactions | 1.60e-05 | 88 | 35 | 4 | int:PDGFB | |
| Interaction | COL11A1 interactions | 1.70e-05 | 29 | 35 | 3 | int:COL11A1 | |
| Interaction | COL18A1 interactions | 2.45e-05 | 98 | 35 | 4 | int:COL18A1 | |
| Interaction | COL6A1 interactions | 4.92e-05 | 117 | 35 | 4 | int:COL6A1 | |
| Interaction | COL8A1 interactions | 7.64e-05 | 131 | 35 | 4 | int:COL8A1 | |
| Interaction | BMP3 interactions | 8.15e-05 | 8 | 35 | 2 | int:BMP3 | |
| Interaction | COL21A1 interactions | 1.05e-04 | 9 | 35 | 2 | int:COL21A1 | |
| Interaction | TIMP2 interactions | 1.10e-04 | 277 | 35 | 5 | int:TIMP2 | |
| Interaction | SPARC interactions | 1.95e-04 | 65 | 35 | 3 | int:SPARC | |
| Interaction | COL5A1 interactions | 1.95e-04 | 65 | 35 | 3 | int:COL5A1 | |
| Interaction | C1QA interactions | 3.21e-04 | 77 | 35 | 3 | int:C1QA | |
| Interaction | CRP interactions | 3.21e-04 | 77 | 35 | 3 | int:CRP | |
| Interaction | FGF7 interactions | 3.46e-04 | 16 | 35 | 2 | int:FGF7 | |
| Interaction | VHL interactions | 3.70e-04 | 561 | 35 | 6 | int:VHL | |
| Interaction | FKBP9 interactions | 4.60e-04 | 87 | 35 | 3 | int:FKBP9 | |
| Interaction | COLEC11 interactions | 4.92e-04 | 19 | 35 | 2 | int:COLEC11 | |
| Interaction | COL14A1 interactions | 5.08e-04 | 90 | 35 | 3 | int:COL14A1 | |
| Interaction | COL6A2 interactions | 5.08e-04 | 90 | 35 | 3 | int:COL6A2 | |
| Interaction | DEFB125 interactions | 5.46e-04 | 20 | 35 | 2 | int:DEFB125 | |
| Interaction | TGM2 interactions | 7.10e-04 | 235 | 35 | 4 | int:TGM2 | |
| Interaction | COL7A1 interactions | 8.57e-04 | 25 | 35 | 2 | int:COL7A1 | |
| Interaction | COL5A2 interactions | 1.16e-03 | 29 | 35 | 2 | int:COL5A2 | |
| Interaction | CFC1 interactions | 1.35e-03 | 126 | 35 | 3 | int:CFC1 | |
| Interaction | APCS interactions | 1.50e-03 | 33 | 35 | 2 | int:APCS | |
| Interaction | VEGFB interactions | 1.59e-03 | 34 | 35 | 2 | int:VEGFB | |
| Interaction | WNT10A interactions | 1.88e-03 | 37 | 35 | 2 | int:WNT10A | |
| Interaction | C1QL1 interactions | 1.98e-03 | 38 | 35 | 2 | int:C1QL1 | |
| Interaction | COL10A1 interactions | 1.98e-03 | 38 | 35 | 2 | int:COL10A1 | |
| Interaction | DEFB135 interactions | 2.42e-03 | 42 | 35 | 2 | int:DEFB135 | |
| Interaction | IL25 interactions | 2.65e-03 | 44 | 35 | 2 | int:IL25 | |
| Interaction | DEFB136 interactions | 2.65e-03 | 44 | 35 | 2 | int:DEFB136 | |
| Interaction | ITGAV interactions | 2.81e-03 | 163 | 35 | 3 | int:ITGAV | |
| Interaction | NID1 interactions | 3.14e-03 | 48 | 35 | 2 | int:NID1 | |
| Interaction | PRG3 interactions | 3.27e-03 | 49 | 35 | 2 | int:PRG3 | |
| Interaction | COL12A1 interactions | 3.41e-03 | 50 | 35 | 2 | int:COL12A1 | |
| Interaction | PTPRK interactions | 3.55e-03 | 177 | 35 | 3 | int:PTPRK | |
| Interaction | ANXA7 interactions | 3.95e-03 | 184 | 35 | 3 | int:ANXA7 | |
| Interaction | INSL5 interactions | 4.56e-03 | 58 | 35 | 2 | int:INSL5 | |
| Interaction | LYPD1 interactions | 4.56e-03 | 58 | 35 | 2 | int:LYPD1 | |
| Cytoband | Xq22 | 1.29e-04 | 22 | 35 | 2 | Xq22 | |
| Cytoband | 21q22.3 | 1.30e-04 | 128 | 35 | 3 | 21q22.3 | |
| Cytoband | 13q34 | 7.88e-04 | 54 | 35 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 1.94e-03 | 85 | 35 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 2.07e-03 | 88 | 35 | 2 | chr13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 2.96e-03 | 377 | 35 | 3 | chr21q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 7.66e-03 | 172 | 35 | 2 | chrXq22 | |
| GeneFamily | Collagens | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 8.71e-60 | 46 | 31 | 24 | 490 |
| GeneFamily | Endogenous ligands|C1q and TNF related | 4.28e-04 | 18 | 31 | 2 | 1372 | |
| GeneFamily | Complement system|Sushi domain containing | 1.73e-03 | 36 | 31 | 2 | 492 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 1.30e-62 | 44 | 34 | 24 | M3005 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 COL27A1 | 1.69e-59 | 43 | 34 | 23 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL28A1 COL27A1 | 5.26e-43 | 275 | 34 | 25 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 OTOL1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 COL27A1 | 8.60e-41 | 270 | 34 | 24 | MM17057 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 ADAM29 COL7A1 OTOL1 C1QTNF3 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 FCN1 COL28A1 COL27A1 | 1.59e-38 | 1026 | 34 | 30 | M5889 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL23A1 COL4A2 COL4A3 COL4A4 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 ADAM29 COL7A1 OTOL1 C1QTNF3 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 FCN1 COL28A1 COL27A1 | 1.44e-36 | 1008 | 34 | 29 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL6A1 COL18A1 COL6A2 COL6A3 | 2.57e-21 | 40 | 34 | 10 | M5887 |
| Coexpression | GU_PDEF_TARGETS_UP | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL16A1 | 2.30e-16 | 71 | 34 | 9 | M3955 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.89e-15 | 29 | 34 | 7 | MM17055 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.97e-13 | 23 | 34 | 6 | M48001 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 3.23e-12 | 33 | 34 | 6 | M9167 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.65e-11 | 17 | 34 | 5 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.65e-11 | 17 | 34 | 5 | MM1297 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | COL4A1 COL4A2 C1QA COL5A1 COL6A1 COL6A2 COL6A3 COL10A1 COL16A1 | 5.01e-10 | 352 | 34 | 9 | M17471 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL27A1 | 5.59e-10 | 505 | 34 | 10 | M39167 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.96e-09 | 41 | 34 | 5 | M47988 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 5.55e-09 | 17 | 34 | 4 | M47995 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 6.12e-09 | 200 | 34 | 7 | M5930 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 7.13e-09 | 18 | 34 | 4 | M47984 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 8.44e-09 | 117 | 34 | 6 | M39300 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.95e-08 | 64 | 34 | 5 | M2572 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.62e-08 | 385 | 34 | 8 | M39264 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 2.93e-08 | 144 | 34 | 6 | M1484 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 COL4A2 COL5A1 COL6A1 COL6A2 COL6A3 COL7A1 COL16A1 COL21A1 COL28A1 | 3.01e-08 | 767 | 34 | 10 | M39209 |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 3.46e-08 | 148 | 34 | 6 | MM1010 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 4.05e-08 | 27 | 34 | 4 | M47994 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 4.08e-08 | 74 | 34 | 5 | M13547 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 4.59e-08 | 268 | 34 | 7 | M45796 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 5.68e-08 | 79 | 34 | 5 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 6.06e-08 | 80 | 34 | 5 | MM1285 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 8.27e-08 | 32 | 34 | 4 | M308 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.20e-07 | 35 | 34 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.35e-07 | 36 | 34 | 4 | MM1212 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.37e-07 | 94 | 34 | 5 | M2580 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.44e-07 | 95 | 34 | 5 | MM1328 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.47e-07 | 318 | 34 | 7 | M41707 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.72e-07 | 194 | 34 | 6 | M39122 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.75e-07 | 493 | 34 | 8 | M19391 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 2.18e-07 | 337 | 34 | 7 | MM16606 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 3.14e-07 | 111 | 34 | 5 | M45685 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 3.38e-07 | 45 | 34 | 4 | M1605 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 3.70e-07 | 46 | 34 | 4 | MM1187 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 4.63e-07 | 120 | 34 | 5 | M42505 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 5.21e-07 | 50 | 34 | 4 | MM403 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 5.90e-07 | 126 | 34 | 5 | M39132 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 7.68e-07 | 55 | 34 | 4 | MM3666 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.02e-06 | 59 | 34 | 4 | M47993 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON | 1.10e-06 | 16 | 34 | 3 | M5718 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 1.12e-06 | 267 | 34 | 6 | M12890 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.51e-06 | 65 | 34 | 4 | M39309 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.99e-06 | 681 | 34 | 8 | M39175 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.28e-06 | 72 | 34 | 4 | M9908 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.29e-06 | 479 | 34 | 7 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.42e-06 | 483 | 34 | 7 | MM1082 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 2.69e-06 | 75 | 34 | 4 | MM1084 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.66e-06 | 81 | 34 | 4 | M39253 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 4.03e-06 | 83 | 34 | 4 | M2448 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 4.69e-06 | 192 | 34 | 5 | M42501 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 5.08e-06 | 26 | 34 | 3 | M47999 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 5.82e-06 | 91 | 34 | 4 | M40180 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 7.21e-06 | 369 | 34 | 6 | MM16610 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 7.42e-06 | 211 | 34 | 5 | M12225 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 8.74e-06 | 31 | 34 | 3 | M18395 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 9.91e-06 | 224 | 34 | 5 | M9893 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 1.06e-05 | 33 | 34 | 3 | M1904 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.27e-05 | 35 | 34 | 3 | MM17054 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 1.50e-05 | 37 | 34 | 3 | MM1258 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 2.05e-05 | 125 | 34 | 4 | M1969 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.07e-05 | 261 | 34 | 5 | M1834 | |
| Coexpression | RB_P107_DN.V1_UP | 2.39e-05 | 130 | 34 | 4 | M2802 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.44e-05 | 6 | 34 | 2 | M48000 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 2.53e-05 | 132 | 34 | 4 | MM841 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 2.66e-05 | 465 | 34 | 6 | M9192 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 2.69e-05 | 134 | 34 | 4 | M13907 | |
| Coexpression | TSENG_ADIPOGENIC_POTENTIAL_DN | 3.11e-05 | 47 | 34 | 3 | M8364 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 3.28e-05 | 141 | 34 | 4 | MM681 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 3.31e-05 | 48 | 34 | 3 | M1246 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES | 3.56e-05 | 144 | 34 | 4 | M41744 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | 3.84e-05 | 740 | 34 | 7 | M41202 | |
| Coexpression | TSENG_ADIPOGENIC_POTENTIAL_DN | 3.98e-05 | 51 | 34 | 3 | MM689 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.22e-05 | 303 | 34 | 5 | M39040 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 4.29e-05 | 151 | 34 | 4 | M8901 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 4.71e-05 | 310 | 34 | 5 | MM16608 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_UP | 4.73e-05 | 54 | 34 | 3 | M6977 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A1 COL4A5 COL5A1 COL22A1 COL11A2 COL16A1 COL19A1 COL28A1 | 4.76e-05 | 1054 | 34 | 8 | M45798 |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 4.99e-05 | 157 | 34 | 4 | MM1099 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.12e-05 | 158 | 34 | 4 | MM17063 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 5.64e-05 | 162 | 34 | 4 | M45037 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 6.17e-05 | 59 | 34 | 3 | M47989 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 6.19e-05 | 541 | 34 | 6 | MM1061 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 6.49e-05 | 60 | 34 | 3 | M16524 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 6.51e-05 | 1102 | 34 | 8 | M2369 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.80e-05 | 170 | 34 | 4 | M5880 | |
| Coexpression | MA_RAT_AGING_DN | 6.80e-05 | 170 | 34 | 4 | MM16097 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 7.48e-05 | 1124 | 34 | 8 | MM1070 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 7.71e-05 | 563 | 34 | 6 | M15103 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 8.31e-05 | 179 | 34 | 4 | M39308 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 8.92e-05 | 11 | 34 | 2 | M47997 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 9.03e-05 | 67 | 34 | 3 | M40194 | |
| Coexpression | WU_CELL_MIGRATION | 9.05e-05 | 183 | 34 | 4 | M2001 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.81e-09 | 141 | 33 | 7 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | COL2A1 C1QC COL6A1 COL24A1 COL6A2 COL6A3 COL7A1 COL16A1 COL25A1 | 3.67e-09 | 371 | 33 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 6.87e-09 | 95 | 33 | 6 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.71e-09 | 276 | 33 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 4.72e-08 | 64 | 33 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 5.52e-08 | 66 | 33 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.39e-08 | 241 | 33 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 7.44e-08 | 70 | 33 | 5 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.04e-08 | 244 | 33 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 9.23e-08 | 249 | 33 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 C1QTNF3 COL16A1 | 2.22e-07 | 797 | 33 | 10 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | COL23A1 COL4A4 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 C1QTNF3 COL16A1 COL27A1 | 2.27e-07 | 799 | 33 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 2.36e-07 | 88 | 33 | 5 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.12e-07 | 298 | 33 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 3.27e-07 | 300 | 33 | 7 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 C1QC COL6A1 COL24A1 COL6A2 COL6A3 COL7A1 COL16A1 COL25A1 | 4.76e-07 | 655 | 33 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.31e-07 | 197 | 33 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 6.25e-07 | 489 | 33 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A1 COL23A1 COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL6A2 COL27A1 | 7.38e-07 | 1153 | 33 | 11 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.45e-06 | 234 | 33 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.71e-06 | 384 | 33 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.13e-06 | 137 | 33 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.29e-06 | 139 | 33 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 4.18e-06 | 281 | 33 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 4.18e-06 | 281 | 33 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500 | 4.36e-06 | 71 | 33 | 4 | gudmap_developingGonad_P2_epididymis_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#3 | 4.57e-06 | 160 | 33 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K3 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 4.62e-06 | 72 | 33 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 5.15e-06 | 74 | 33 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.31e-06 | 293 | 33 | 6 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 5.38e-06 | 457 | 33 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 6.50e-06 | 172 | 33 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 7.31e-06 | 479 | 33 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 9.75e-06 | 27 | 33 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL2A1 C1QC COL6A1 COL24A1 COL6A2 COL6A3 COL7A1 COL16A1 COL25A1 | 1.16e-05 | 967 | 33 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.22e-05 | 196 | 33 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 1.23e-05 | 92 | 33 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.26e-05 | 197 | 33 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL2A1 C1QC COL6A1 COL24A1 COL6A2 COL6A3 COL7A1 COL16A1 COL25A1 | 1.27e-05 | 978 | 33 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 1.34e-05 | 94 | 33 | 4 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | COL2A1 C1QC COL6A1 COL24A1 COL6A2 COL6A3 COL7A1 COL16A1 COL25A1 | 1.34e-05 | 984 | 33 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.39e-05 | 529 | 33 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.59e-05 | 207 | 33 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.71e-05 | 100 | 33 | 4 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.71e-05 | 100 | 33 | 4 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_200 | 1.81e-05 | 33 | 33 | 3 | gudmap_developingGonad_P2_epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.87e-05 | 214 | 33 | 5 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.91e-05 | 215 | 33 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.92e-05 | 103 | 33 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.97e-05 | 369 | 33 | 6 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.99e-05 | 104 | 33 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.15e-05 | 790 | 33 | 8 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.59e-05 | 229 | 33 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.87e-05 | 234 | 33 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_500 | 3.17e-05 | 117 | 33 | 4 | gudmap_developingGonad_P2_testes_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 3.28e-05 | 404 | 33 | 6 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.44e-05 | 243 | 33 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k1 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 3.66e-05 | 615 | 33 | 7 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.57e-05 | 878 | 33 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.75e-05 | 447 | 33 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.75e-05 | 142 | 33 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k2 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.03e-05 | 951 | 33 | 8 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 8.83e-05 | 483 | 33 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 9.02e-05 | 967 | 33 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 9.02e-05 | 967 | 33 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 9.09e-05 | 968 | 33 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 9.13e-05 | 486 | 33 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 9.35e-05 | 972 | 33 | 8 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 9.63e-05 | 976 | 33 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.08e-04 | 501 | 33 | 6 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.08e-04 | 501 | 33 | 6 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.08e-04 | 501 | 33 | 6 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 1.10e-04 | 60 | 33 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 1.24e-04 | 166 | 33 | 4 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 1.24e-04 | 166 | 33 | 4 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.25e-04 | 319 | 33 | 5 | gudmap_developingGonad_P2_testes_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | 1.40e-04 | 761 | 33 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 | |
| CoexpressionAtlas | BM Top 100 - cervix | 1.46e-04 | 66 | 33 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.46e-04 | 66 | 33 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.47e-04 | 530 | 33 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200 | 1.51e-04 | 175 | 33 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 1.60e-04 | 778 | 33 | 7 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.67e-04 | 69 | 33 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 1.74e-04 | 70 | 33 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.83e-04 | 184 | 33 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.92e-04 | 801 | 33 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.97e-04 | 73 | 33 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 2.06e-04 | 74 | 33 | 3 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 2.12e-04 | 814 | 33 | 7 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.40e-04 | 78 | 33 | 3 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 2.40e-04 | 78 | 33 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 2.40e-04 | 78 | 33 | 3 | GSM605853_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_100 | 2.43e-04 | 15 | 33 | 2 | gudmap_developingGonad_P2_epididymis_100_k1 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 2.59e-04 | 80 | 33 | 3 | GSM605856_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3 | 2.69e-04 | 81 | 33 | 3 | GSM476672_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.72e-04 | 204 | 33 | 4 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.77e-04 | 379 | 33 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_100 | 2.79e-04 | 82 | 33 | 3 | gudmap_developingGonad_P2_epididymis_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 2.82e-04 | 206 | 33 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 2.99e-04 | 84 | 33 | 3 | GSM605862_100 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 COL11A2 COL16A1 | 3.61e-16 | 198 | 35 | 10 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL21A1 COL27A1 | 3.80e-16 | 199 | 35 | 10 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL2A1 COL6A1 COL6A2 COL6A3 C1QTNF3 COL10A1 COL11A2 COL16A1 COL27A1 | 6.62e-15 | 166 | 35 | 9 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL2A1 COL6A1 COL6A2 COL6A3 C1QTNF3 COL10A1 COL11A2 COL16A1 COL27A1 | 6.62e-15 | 166 | 35 | 9 | 81c546c6d847e49e662b81e71992ca0f7a99e890 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL4A1 COL23A1 COL4A2 COL5A1 COL24A1 COL6A2 COL7A1 COL22A1 COL27A1 | 1.53e-14 | 182 | 35 | 9 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | COL5A1 COL6A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL16A1 COL27A1 | 1.69e-14 | 184 | 35 | 9 | 0b336489c10e8c3c957795dd845454f03404382b |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL24A1 COL6A2 COL6A3 COL16A1 | 2.06e-14 | 188 | 35 | 9 | b382d18fb09fb2869f3c151efa71540a7f5ed229 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL27A1 | 2.06e-14 | 188 | 35 | 9 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 COL5A1 COL6A1 COL24A1 COL6A2 COL6A3 COL11A2 COL16A1 COL27A1 | 2.06e-14 | 188 | 35 | 9 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | COL4A1 COL4A2 COL5A1 COL6A1 COL24A1 COL6A2 COL6A3 COL16A1 COL27A1 | 2.16e-14 | 189 | 35 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | COL4A1 COL4A2 COL4A4 COL5A1 COL6A1 COL18A1 COL6A2 COL7A1 COL22A1 | 2.16e-14 | 189 | 35 | 9 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL6A1 COL24A1 COL6A2 COL6A3 | 2.49e-14 | 192 | 35 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL6A3 COL11A2 COL16A1 | 2.87e-14 | 195 | 35 | 9 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL6A2 COL6A3 COL16A1 COL27A1 | 3.15e-14 | 197 | 35 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL6A2 COL6A3 COL16A1 COL27A1 | 3.15e-14 | 197 | 35 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 COL16A1 COL27A1 | 3.15e-14 | 197 | 35 | 9 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 | 3.30e-14 | 198 | 35 | 9 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 | 3.30e-14 | 198 | 35 | 9 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COL6A1 COL6A2 COL6A3 C1QTNF3 COL22A1 COL11A2 COL16A1 | 3.30e-14 | 198 | 35 | 9 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL5A1 COL6A1 COL6A2 COL6A3 C1QTNF3 COL16A1 COL21A1 | 3.45e-14 | 199 | 35 | 9 | 84545ced0c792bc77980a50d65e484eab648d47e |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL5A1 COL6A1 COL6A2 COL6A3 C1QTNF3 COL16A1 COL21A1 | 3.45e-14 | 199 | 35 | 9 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 COL27A1 | 3.45e-14 | 199 | 35 | 9 | ec74ff85d6b61013b1f785b2fca343759feb7843 |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL4A1 COL23A1 COL4A2 COL4A5 COL4A6 COL5A1 COL6A1 COL6A2 COL6A3 | 3.45e-14 | 199 | 35 | 9 | 3368c0a90a47c4dcdfe70be3192550df0744e508 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL10A1 COL16A1 | 3.61e-14 | 200 | 35 | 9 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL10A1 COL16A1 | 3.61e-14 | 200 | 35 | 9 | 444c72334df421375ae6fc69b0adfd4950d49a43 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL10A1 COL16A1 | 3.61e-14 | 200 | 35 | 9 | 5826c17da67bdaba3a828792279004218d8260c8 |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A1 COL4A2 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL25A1 COL27A1 | 3.61e-14 | 200 | 35 | 9 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL2A1 COL4A1 COL4A2 COL5A1 COL6A1 COL6A2 COL6A3 COL11A2 COL16A1 | 3.61e-14 | 200 | 35 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.24e-13 | 153 | 35 | 8 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.24e-13 | 153 | 35 | 8 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.24e-13 | 153 | 35 | 8 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.42e-13 | 159 | 35 | 8 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 9.16e-13 | 174 | 35 | 8 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-12 | 180 | 35 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-12 | 180 | 35 | 8 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-12 | 183 | 35 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-12 | 183 | 35 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-12 | 183 | 35 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-12 | 185 | 35 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-12 | 187 | 35 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.86e-12 | 190 | 35 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.94e-12 | 191 | 35 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-12 | 193 | 35 | 8 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.11e-12 | 193 | 35 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.20e-12 | 194 | 35 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.20e-12 | 194 | 35 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-12 | 195 | 35 | 8 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.29e-12 | 195 | 35 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-12 | 195 | 35 | 8 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.39e-12 | 196 | 35 | 8 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-12 | 197 | 35 | 8 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-12 | 197 | 35 | 8 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-12 | 198 | 35 | 8 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-12 | 198 | 35 | 8 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-12 | 198 | 35 | 8 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-12 | 198 | 35 | 8 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-12 | 198 | 35 | 8 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-12 | 198 | 35 | 8 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-12 | 198 | 35 | 8 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-12 | 198 | 35 | 8 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-12 | 198 | 35 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.59e-12 | 198 | 35 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.59e-12 | 198 | 35 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.70e-12 | 199 | 35 | 8 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.70e-12 | 199 | 35 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.70e-12 | 199 | 35 | 8 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.70e-12 | 199 | 35 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.81e-12 | 200 | 35 | 8 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-12 | 200 | 35 | 8 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.81e-12 | 200 | 35 | 8 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.81e-12 | 200 | 35 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.81e-12 | 200 | 35 | 8 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.53e-12 | 114 | 35 | 7 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.53e-12 | 114 | 35 | 7 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.25e-11 | 162 | 35 | 7 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.64e-11 | 164 | 35 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-11 | 169 | 35 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 6.22e-11 | 171 | 35 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-11 | 176 | 35 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-11 | 176 | 35 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-11 | 177 | 35 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-11 | 177 | 35 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-11 | 178 | 35 | 7 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.93e-11 | 180 | 35 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.93e-11 | 180 | 35 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.28e-11 | 181 | 35 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.28e-11 | 181 | 35 | 7 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.65e-11 | 182 | 35 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.00e-10 | 183 | 35 | 7 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-10 | 184 | 35 | 7 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-10 | 185 | 35 | 7 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.17e-10 | 187 | 35 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-10 | 187 | 35 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-10 | 187 | 35 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-10 | 188 | 35 | 7 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-10 | 188 | 35 | 7 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-10 | 189 | 35 | 7 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-10 | 189 | 35 | 7 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.26e-10 | 189 | 35 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-10 | 190 | 35 | 7 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| Computational | Adhesion molecules. | COL4A1 COL4A5 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL16A1 | 3.83e-12 | 141 | 22 | 9 | MODULE_122 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.40e-08 | 50 | 22 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | ECM and collagens. | 2.09e-07 | 225 | 22 | 7 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.85e-06 | 50 | 22 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Neighborhood of CDH11 | 1.66e-05 | 25 | 22 | 3 | GNF2_CDH11 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.37e-04 | 50 | 22 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.37e-04 | 50 | 22 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.37e-04 | 50 | 22 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Immune (humoral) and inflammatory response. | 6.20e-04 | 546 | 22 | 6 | MODULE_84 | |
| Computational | Spinal cord (neuro-development) genes. | 6.74e-04 | 360 | 22 | 5 | MODULE_12 | |
| Computational | Ovary genes. | 7.45e-04 | 368 | 22 | 5 | MODULE_1 | |
| Computational | Genes in the cancer module 55. | 9.85e-04 | 832 | 22 | 7 | MODULE_55 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 1.01e-03 | 835 | 22 | 7 | MODULE_88 | |
| Computational | Lung genes. | 1.56e-03 | 434 | 22 | 5 | MODULE_5 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 1.89e-03 | 453 | 22 | 5 | MODULE_24 | |
| Computational | Placenta genes. | 2.08e-03 | 463 | 22 | 5 | MODULE_38 | |
| Computational | Thymus genes. | 3.90e-03 | 325 | 22 | 4 | MODULE_44 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.62e-03 | 50 | 22 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Drug | GK-101 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 4.11e-50 | 36 | 35 | 20 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 3.14e-47 | 46 | 35 | 20 | CID000108062 |
| Drug | AC1LAKND | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 6.74e-47 | 62 | 35 | 21 | CID000470146 |
| Drug | d-indobufen | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 2.63e-46 | 50 | 35 | 20 | CID000044562 |
| Drug | hydroxylysine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 C1QA COL4A6 COL5A1 C1QC COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 2.91e-46 | 109 | 35 | 23 | CID000001029 |
| Drug | ridogrel | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 7.02e-46 | 52 | 35 | 20 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 1.13e-45 | 53 | 35 | 20 | CID000023340 |
| Drug | BAPN | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.99e-45 | 71 | 35 | 21 | CID000001647 |
| Drug | halofuginone lactate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.57e-43 | 85 | 35 | 21 | CID000062891 |
| Drug | 4-hydroxyproline | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 7.95e-43 | 91 | 35 | 21 | CID000000825 |
| Drug | malotilate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 1.24e-42 | 71 | 35 | 20 | CID000004006 |
| Drug | AC1NMZ1B | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 4.41e-42 | 75 | 35 | 20 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 8.08e-42 | 77 | 35 | 20 | CID006918182 |
| Drug | ticlopidine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.46e-41 | 103 | 35 | 21 | CID000005472 |
| Drug | Tranilast sodium | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.87e-40 | 115 | 35 | 21 | CID000005527 |
| Drug | pirfenidone | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.19e-38 | 138 | 35 | 21 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.41e-38 | 139 | 35 | 21 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.41e-38 | 139 | 35 | 21 | CID000002806 |
| Drug | AC1L1C2F | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 2.36e-38 | 110 | 35 | 20 | CID000001711 |
| Drug | PPACK | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 4.25e-38 | 113 | 35 | 20 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 5.15e-38 | 114 | 35 | 20 | CID000439300 |
| Drug | Selara | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 3.81e-37 | 125 | 35 | 20 | CID000150310 |
| Drug | DMSe | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 1.23e-36 | 132 | 35 | 20 | CID000020796 |
| Drug | khellin | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.46e-36 | 171 | 35 | 21 | CID000003828 |
| Drug | AC1L1DD6 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 4.03e-36 | 179 | 35 | 21 | CID000002299 |
| Drug | candesartan cilexetil | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 9.24e-36 | 145 | 35 | 20 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 9.75e-35 | 162 | 35 | 20 | CID000072363 |
| Drug | AC1Q6PCP | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 9.99e-34 | 230 | 35 | 21 | CID000005267 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 2.51e-33 | 189 | 35 | 20 | CID000001413 |
| Drug | foscarnet | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 2.80e-33 | 190 | 35 | 20 | CID000003414 |
| Drug | hyaluronan | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.85e-32 | 263 | 35 | 21 | CID000024759 |
| Drug | silibinin | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.05e-31 | 285 | 35 | 21 | CID000005213 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 8.42e-31 | 250 | 35 | 20 | CID000000159 |
| Drug | AC1L18QD | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 1.78e-30 | 325 | 35 | 21 | CID000000213 |
| Drug | losartan | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 4.52e-29 | 378 | 35 | 21 | CID000003961 |
| Drug | colchine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 5.99e-29 | 383 | 35 | 21 | CID000002833 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 9.08e-29 | 314 | 35 | 20 | CID000447989 |
| Drug | chondroitin sulfate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 2.99e-28 | 413 | 35 | 21 | CID000024766 |
| Drug | AC1L1KMJ | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 6.08e-27 | 476 | 35 | 21 | CID000030956 |
| Drug | L-3,4-dehydroproline | COL2A1 COL23A1 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL16A1 COL25A1 COL19A1 COL21A1 | 7.09e-27 | 73 | 35 | 14 | CID000094284 |
| Drug | Y-27632 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 1.03e-25 | 444 | 35 | 20 | CID000005711 |
| Drug | aspirin | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 2.10e-25 | 563 | 35 | 21 | CID000002244 |
| Drug | LMWH | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL21A1 COL27A1 | 3.13e-22 | 663 | 35 | 20 | CID000000772 |
| Drug | LS-63783 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A1 COL18A1 COL24A1 COL6A2 COL6A3 COL7A1 COL10A1 COL22A1 COL11A2 COL16A1 COL25A1 COL19A1 COL21A1 COL27A1 | 3.62e-22 | 804 | 35 | 21 | CID000000231 |
| Drug | dermatan sulfate | COL2A1 COL4A3 COL4A5 COL5A1 COL6A1 COL6A2 COL6A3 COL11A2 COL21A1 COL27A1 | 8.59e-13 | 220 | 35 | 10 | CID000032756 |
| Drug | AC1L9HPX | 1.12e-12 | 92 | 35 | 8 | CID000445279 | |
| Drug | isodesmosine | 9.03e-12 | 33 | 35 | 6 | CID000013811 | |
| Drug | NC-4 | 5.69e-11 | 44 | 35 | 6 | CID006420119 | |
| Drug | 351A | 9.71e-11 | 20 | 35 | 5 | CID000122144 | |
| Drug | pyridinoline | 1.44e-10 | 99 | 35 | 7 | CID000105068 | |
| Drug | desmosine | 1.83e-10 | 53 | 35 | 6 | CID000025435 | |
| Drug | 4-aminoazobenzene | 7.14e-10 | 66 | 35 | 6 | CID000006051 | |
| Drug | 2-amino-4,6-dinitrotoluene | 1.03e-09 | 70 | 35 | 6 | ctd:C035208 | |
| Drug | Sirius red | 2.00e-09 | 35 | 35 | 5 | CID005486818 | |
| Drug | sodium chloride | COL4A3 COL4A5 COL5A1 COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL10A1 COL25A1 COL21A1 FCN1 | 3.12e-09 | 865 | 35 | 12 | CID000000206 |
| Drug | CP-331 | 3.33e-09 | 3 | 35 | 3 | CID000130967 | |
| Drug | AC1MRIIV | 3.53e-09 | 39 | 35 | 5 | CID003518584 | |
| Drug | PD123177 | 5.88e-09 | 43 | 35 | 5 | CID000114899 | |
| Drug | cyclophorine | COL4A1 COL4A3 COL4A5 COL4A6 COL6A1 COL6A2 COL6A3 COL7A1 FKBP2 | 1.19e-08 | 426 | 35 | 9 | CID000002909 |
| Drug | alpha-methyl-D-mannoside | 2.21e-08 | 116 | 35 | 6 | CID000002108 | |
| Drug | trapidil | 2.52e-08 | 57 | 35 | 5 | CID000005531 | |
| Drug | AC1Q641C | 3.87e-08 | 62 | 35 | 5 | CID000005005 | |
| Drug | BPAT-143 | 6.63e-08 | 6 | 35 | 3 | CID000146249 | |
| Drug | Paclitaxel | COL4A1 COL4A2 C1QA C1QC COL6A1 COL18A1 COL6A2 COL6A3 COL7A1 COL11A2 | 8.43e-08 | 720 | 35 | 10 | ctd:D017239 |
| Drug | homocystine | 1.60e-07 | 82 | 35 | 5 | CID000010010 | |
| Drug | Pcme | 1.85e-07 | 8 | 35 | 3 | CID000169849 | |
| Drug | pyrachlostrobin | COL4A1 COL4A5 C1QA COL4A6 COL5A1 C1QC COL18A1 COL22A1 COL16A1 COL19A1 | 2.54e-07 | 811 | 35 | 10 | ctd:C513428 |
| Drug | dimethylnitrosamine | 4.97e-07 | 196 | 35 | 6 | CID000006124 | |
| Drug | Rgd Peptide | 1.58e-06 | 239 | 35 | 6 | CID000104802 | |
| Drug | 1h00 | 1.62e-06 | 56 | 35 | 4 | CID000445950 | |
| Drug | calcium phosphate | 3.11e-06 | 149 | 35 | 5 | CID000024441 | |
| Drug | AC1NDXNT | 3.77e-06 | 69 | 35 | 4 | CID004633270 | |
| Drug | angiotensin | 4.11e-06 | 282 | 35 | 6 | CID003083715 | |
| Drug | Coal Ash | 4.27e-06 | 159 | 35 | 5 | ctd:D060729 | |
| Drug | diphenylamine-2-carboxylate | 4.97e-06 | 164 | 35 | 5 | CID000004386 | |
| Drug | 8-azaguanine | 6.16e-06 | 78 | 35 | 4 | CID000008646 | |
| Drug | AC1L1IIA | 6.27e-06 | 172 | 35 | 5 | CID000004591 | |
| Drug | 17-isoprogesterone | COL2A1 COL4A3 COL4A5 COL5A1 COL6A1 COL7A1 COL11A2 COL16A1 COL21A1 COL27A1 | 6.98e-06 | 1170 | 35 | 10 | CID000004920 |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.62e-06 | 179 | 35 | 5 | 7103_DN | |
| Drug | Sialic acids | 9.92e-06 | 329 | 35 | 6 | CID000349960 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 1.09e-05 | 90 | 35 | 4 | CID015942693 | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 1.15e-05 | 195 | 35 | 5 | 2538_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.24e-05 | 198 | 35 | 5 | 2269_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.30e-05 | 200 | 35 | 5 | 6029_UP | |
| Drug | peroben | 1.37e-05 | 4 | 35 | 2 | ctd:C008814 | |
| Drug | Brn 2557402 | 1.37e-05 | 4 | 35 | 2 | CID000042742 | |
| Drug | hydroxyl radical | 1.50e-05 | 206 | 35 | 5 | CID000157350 | |
| Drug | Penicillins | 1.65e-05 | 100 | 35 | 4 | CID009548591 | |
| Drug | phenytoin | 2.02e-05 | 219 | 35 | 5 | CID000001775 | |
| Drug | Cyclo-rgdphg | 2.29e-05 | 5 | 35 | 2 | CID006449872 | |
| Drug | dimethylmalonimidate | 2.29e-05 | 5 | 35 | 2 | CID000189133 | |
| Drug | 3-C-4 | 2.71e-05 | 38 | 35 | 3 | CID000118534 | |
| Drug | haloperidol | 2.74e-05 | 394 | 35 | 6 | CID000003559 | |
| Drug | mitomycin C | 3.19e-05 | 241 | 35 | 5 | CID000005746 | |
| Drug | gold nanoparticles | 3.32e-05 | 243 | 35 | 5 | CID000023985 | |
| Drug | 4-fluoranylproline | 3.43e-05 | 6 | 35 | 2 | CID000450594 | |
| Drug | balofloxacin | 3.67e-05 | 42 | 35 | 3 | CID000065958 | |
| Drug | 1-Naphthylisothiocyanate | 4.17e-05 | 871 | 35 | 8 | ctd:D015058 | |
| Drug | 2,3-pentanedione | 4.49e-05 | 129 | 35 | 4 | ctd:C013186 | |
| Drug | 1i32 | 4.49e-05 | 129 | 35 | 4 | CID000446186 | |
| Disease | collagen disease (implicated_via_orthology) | 1.37e-12 | 12 | 35 | 5 | DOID:854 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.10e-11 | 48 | 35 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | Alport syndrome | 1.53e-09 | 3 | 35 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.53e-09 | 3 | 35 | 3 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 6.11e-09 | 4 | 35 | 3 | C0241908 | |
| Disease | Bethlem myopathy (is_implicated_in) | 6.11e-09 | 4 | 35 | 3 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 6.11e-09 | 4 | 35 | 3 | cv:C4551860 | |
| Disease | Bethlem myopathy | 6.11e-09 | 4 | 35 | 3 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 6.11e-09 | 4 | 35 | 3 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 6.11e-09 | 4 | 35 | 3 | DOID:0050558 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 6.11e-09 | 4 | 35 | 3 | C0410179 | |
| Disease | Alport Syndrome | 6.11e-09 | 4 | 35 | 3 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 1.53e-08 | 5 | 35 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.53e-08 | 5 | 35 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.53e-08 | 5 | 35 | 3 | C1567744 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.66e-07 | 53 | 35 | 4 | C4707243 | |
| Disease | Hereditary hearing loss and deafness | 7.97e-07 | 146 | 35 | 5 | cv:C0236038 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 1.37e-06 | 2 | 35 | 2 | C1839884 | |
| Disease | benign familial hematuria (is_implicated_in) | 1.37e-06 | 2 | 35 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Developmental Porencephaly | 1.37e-06 | 2 | 35 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 1.37e-06 | 2 | 35 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 1.37e-06 | 2 | 35 | 2 | C0302892 | |
| Disease | Alport syndrome, recessive type | 1.37e-06 | 2 | 35 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.37e-06 | 2 | 35 | 2 | C2931253 | |
| Disease | Megaepiphyseal dwarfism | 1.37e-06 | 2 | 35 | 2 | C1855310 | |
| Disease | Porencephaly | 1.37e-06 | 2 | 35 | 2 | C4082173 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 1.37e-06 | 2 | 35 | 2 | C4520892 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 1.37e-06 | 2 | 35 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | PORENCEPHALY, FAMILIAL | 1.37e-06 | 2 | 35 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.37e-06 | 2 | 35 | 2 | C3281105 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.37e-06 | 2 | 35 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.37e-06 | 2 | 35 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.37e-06 | 2 | 35 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 1.37e-06 | 2 | 35 | 2 | cv:C0241908 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 1.37e-06 | 2 | 35 | 2 | C4551998 | |
| Disease | Leiomyoma, Epithelioid | 1.37e-06 | 2 | 35 | 2 | C0086533 | |
| Disease | Stickler syndrome, type 3 | 1.37e-06 | 2 | 35 | 2 | C1861481 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.46e-06 | 19 | 35 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | intraocular pressure measurement | 1.93e-06 | 509 | 35 | 7 | EFO_0004695 | |
| Disease | Renal glomerular disease | 2.66e-06 | 23 | 35 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.66e-06 | 23 | 35 | 3 | C4521256 | |
| Disease | Liver Cirrhosis, Experimental | 2.72e-06 | 774 | 35 | 8 | C0023893 | |
| Disease | Alport syndrome (is_implicated_in) | 4.10e-06 | 3 | 35 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 4.10e-06 | 3 | 35 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 4.10e-06 | 3 | 35 | 2 | cv:C3281105 | |
| Disease | C1q DEFICIENCY | 4.10e-06 | 3 | 35 | 2 | C3150902 | |
| Disease | C1Q deficiency | 4.10e-06 | 3 | 35 | 2 | cv:C3150902 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 4.10e-06 | 3 | 35 | 2 | 614519 | |
| Disease | MRNA-decapping enzyme 1A measurement | 8.19e-06 | 4 | 35 | 2 | EFO_0802757 | |
| Disease | Early Pregnancy Loss | 8.44e-06 | 109 | 35 | 4 | C3830362 | |
| Disease | Miscarriage | 8.44e-06 | 109 | 35 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 8.44e-06 | 109 | 35 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 8.44e-06 | 109 | 35 | 4 | C0000822 | |
| Disease | Stickler syndrome | 1.36e-05 | 5 | 35 | 2 | cv:C0265253 | |
| Disease | corneal resistance factor | 1.37e-05 | 451 | 35 | 6 | EFO_0010067 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 2.04e-05 | 6 | 35 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Cartilage Diseases | 2.04e-05 | 6 | 35 | 2 | C0007302 | |
| Disease | hypertensive nephropathy | 2.04e-05 | 6 | 35 | 2 | C0848548 | |
| Disease | Chondromalacia | 2.04e-05 | 6 | 35 | 2 | C0085700 | |
| Disease | central corneal thickness | 3.06e-05 | 309 | 35 | 5 | EFO_0005213 | |
| Disease | Hematuria | 4.89e-05 | 9 | 35 | 2 | C0018965 | |
| Disease | complement C1q subcomponent subunit C measurement | 6.11e-05 | 10 | 35 | 2 | EFO_0801492 | |
| Disease | Retinal Detachment | 7.47e-05 | 11 | 35 | 2 | C0035305 | |
| Disease | Sensory hearing loss | 7.47e-05 | 11 | 35 | 2 | C1691779 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 7.47e-05 | 11 | 35 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 8.95e-05 | 12 | 35 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Disproportionate short stature | 1.05e-04 | 77 | 35 | 3 | C0878659 | |
| Disease | cognitive decline measurement | 2.56e-04 | 486 | 35 | 5 | EFO_0007710 | |
| Disease | corneal topography | 2.94e-04 | 109 | 35 | 3 | EFO_0004345 | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.40e-04 | 23 | 35 | 2 | C0018784 | |
| Disease | Nephrotic Syndrome | 4.71e-04 | 27 | 35 | 2 | C0027726 | |
| Disease | Cerebral Hemorrhage | 5.07e-04 | 28 | 35 | 2 | C2937358 | |
| Disease | waist-hip ratio | 5.09e-04 | 1226 | 35 | 7 | EFO_0004343 | |
| Disease | spontaneous coronary artery dissection | 6.22e-04 | 31 | 35 | 2 | EFO_0010820 | |
| Disease | social communication impairment | 6.63e-04 | 32 | 35 | 2 | EFO_0005427 | |
| Disease | Complement deficiency disease | 7.05e-04 | 33 | 35 | 2 | C0272242 | |
| Disease | Heart Failure, Diastolic | 7.05e-04 | 33 | 35 | 2 | C1135196 | |
| Disease | retinal detachment, retinal break | 7.94e-04 | 35 | 35 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | Focal glomerulosclerosis | 8.40e-04 | 36 | 35 | 2 | C0017668 | |
| Disease | Cataract | 8.87e-04 | 37 | 35 | 2 | C0086543 | |
| Disease | cervical cancer | 1.04e-03 | 40 | 35 | 2 | MONDO_0002974 | |
| Disease | pulse pressure measurement | 1.08e-03 | 1392 | 35 | 7 | EFO_0005763 | |
| Disease | end stage renal disease (is_implicated_in) | 1.09e-03 | 41 | 35 | 2 | DOID:783 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGYGGSVDSGPPPKR | 656 | Q9UKF5 | |
| FPGLLGPYGPKGDKG | 81 | Q14031 | |
| GLPGPKGEKGYPGIG | 1201 | Q14031 | |
| KGEKGYPGIGIGAPG | 1206 | Q14031 | |
| KVGYPGPSGPLGARG | 81 | P02745 | |
| YLGSPGIPGVDGPKG | 456 | Q01955 | |
| DGVEKPGPRPPYKGD | 211 | Q9BUH8 | |
| GPPGLPGIKGERGYT | 1096 | Q07092 | |
| GAKGEKGIPGFPGPR | 296 | P53420 | |
| PGPPGRKGDTGEDGY | 1426 | P53420 | |
| GYQGPDGPRGPKGEA | 326 | P08572 | |
| EAGKPGKAGERGPPG | 256 | P02458 | |
| GTGPLGEKGERGYPG | 336 | P02462 | |
| GEKGERGYPGTPGPR | 341 | P02462 | |
| GYPGSPGLPGEKGDK | 1106 | P02462 | |
| PGRGFPGFPGAKGDK | 1171 | P02462 | |
| GYGERGAPPKIPGGA | 111 | P26885 | |
| PKGEKGAPGDFGPRG | 161 | Q86Y22 | |
| YKGEIGFPGRPGRPG | 1216 | P39060 | |
| GYPGIPGPKGESIRG | 1366 | P39060 | |
| GEKGAMGEPGPRGPY | 571 | Q9BXS0 | |
| QGPLGYPGPRGVKGV | 711 | P13942 | |
| EKGKLGVPGLPGYPG | 791 | P13942 | |
| YGARGKVPPGAGPGS | 86 | Q6ZUF6 | |
| PGKAGPVGPKGDRGE | 81 | O00602 | |
| GKDGYDGLPGPKGEP | 46 | P02747 | |
| HGPKGEKGYPGIPPE | 101 | Q9BXJ4 | |
| KGEAGERGPGGIPGY | 276 | Q2UY09 | |
| ERGPGGIPGYKGDKG | 281 | Q2UY09 | |
| GKPGIKGDKGSPGPY | 301 | Q2UY09 | |
| RGPVGAPGLKGDGYP | 626 | Q2UY09 | |
| PGEAGPIGPKGYRGD | 466 | P12109 | |
| GVKGAKGYRGPEGPQ | 566 | P12109 | |
| GREGPKGSKGERGYP | 741 | Q14993 | |
| KGSKGERGYPGIPGE | 746 | Q14993 | |
| GDPGYPGEPGRDGEK | 316 | P29400 | |
| PKGIPGEDGYRGYPG | 2051 | P12111 | |
| RRGKKGERGFPGYPG | 2306 | P12111 | |
| RGPPGEIGAKGSKGY | 381 | P12110 | |
| LPGYKGEPGRDGDKG | 501 | Q96P44 | |
| PGEKGKLGVPGLPGY | 861 | P20908 | |
| PVGDPGPKGSRGYIG | 746 | Q8IZC6 | |
| GVPGKPGEPGFKGER | 1381 | Q8NFW1 | |
| GPKGEKGDVGPAGPR | 1551 | Q02388 | |
| PKGDRGFDGQPGPKG | 2681 | Q02388 | |
| PGVVGPQGPRGYKGE | 136 | A6NHN0 | |
| ERGDQGVPGYPGKPG | 156 | A6NHN0 | |
| GGAGEPPKPDKLYGD | 66 | Q8IV56 | |
| EGGLGPREGPPYEGK | 216 | Q8N9Y4 | |
| KPGERGPYGPKGDVG | 116 | Q03692 | |
| PAGPAGYPGAKGERG | 366 | Q03692 | |
| KGERGSPGSDGKPGY | 376 | Q03692 | |
| GEPGYPGDKGAVGLP | 726 | Q17RW2 | |
| GELGPRGKPGQKGYA | 816 | Q17RW2 | |
| RGKPGQKGYAGEPGP | 821 | Q17RW2 | |
| QKGYAGEPGPEGLKG | 826 | Q17RW2 | |
| SGLPGPKGEKGYPGE | 1181 | Q17RW2 |